CFDE Data Portal | Search RPSAP13

	Label	Description
	RPSAP13 Gene (Entity type)	ENSG00000233924 - ribosomal protein SA pseudogene 13
	GSE120210 GSE120214 TBXT brachyury inhibition 1 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE145285 PRMT5 p53 inhibition RNA Messenger 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE213988 RRM2 knockdown 0 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GTEx AdrenalGland 20-29 vs 40-49 Down Gene Set (Entity type)	A Gene Set from GTEx
	GPR6 IDG GPCR ARCHS4 coexpression Gene Set (Entity type)	A Gene Set from IDG
	GTEx Nerve 20-29 vs 30-39 Down Gene Set (Entity type)	A Gene Set from GTEx
	RXFP4 IDG GPCR ARCHS4 coexpression Gene Set (Entity type)	A Gene Set from IDG
	GSE230634 PARP inhibition 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE185200 GSE185202 L-13 Ali-BL 0 v 5 human dn Gene Set (Entity type)	A Gene Set from LINCS

RPSAP13

ENSG00000233924 - ribosomal protein SA pseudogene 13

GSE120210 GSE120214 TBXT brachyury inhibition 1 v 3 human up

A Gene Set from LINCS

GSE145285 PRMT5 p53 inhibition RNA Messenger 0 v 1 human up

A Gene Set from LINCS

GSE213988 RRM2 knockdown 0 v 1 human dn

A Gene Set from LINCS

GTEx AdrenalGland 20-29 vs 40-49 Down

A Gene Set from GTEx

GPR6 IDG GPCR ARCHS4 coexpression

A Gene Set from IDG

GTEx Nerve 20-29 vs 30-39 Down

A Gene Set from GTEx

RXFP4 IDG GPCR ARCHS4 coexpression

A Gene Set from IDG

GSE230634 PARP inhibition 0 v 1 human up

A Gene Set from LINCS

GSE185200 GSE185202 L-13 Ali-BL 0 v 5 human dn

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.